Comorbidity of Pulmonary Fibrosis and COPD/Emphysema: Research Status, Trends, and Future Directions --------- A Bibliometric Analysis from 2004 to 2023

References

• Olson AL, Patnaik P, Hartmann N, Bohn RL, Garry EM, Wallace L. Prevalence and incidence of chronic fibrosing interstitial lung diseases with a progressive phenotype in the United States estimated in a large claims database analysis. Adv Ther. 2021;38(7):4100–4114. doi:10.1007/s12325-021-01786-8
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. 2020 global strategy for prevention, diagnosis and man- agement of COPD[EB/OL]; 2021. Available from: https://gold-copd.org/gold-report. Accessed September 4, 2023.
   Google Scholar
• Yong-Mi K, Delen D. Medical informatics research trend analysis: a text mining approach. Health Informatics J. 2018;24(4):432–452. doi:10.1177/1460458216678443
   PubMed Web of Science ®Google Scholar
• Synnestvedt MB, Chen C, Holmes JH. Citespace II: visualization and knowledge discovery in bibliographic databases. AMIA Annu Symp Proc. 2005;2005:724–728. doi:10.1002/asi.20317
   PubMedGoogle Scholar
• Chen CM, Ibekwe-SanJuan F, Hou JH. The structure and dynamics of cocitation clusters: a multiple-perspective cocitation analysis. J Am Soc Inf Sci Technol. 2010;61(7):1386–1409. doi:10.1002/asi.21309
   Web of Science ®Google Scholar
• Qin Y, Zhang Q, Liu Y. Analysis of knowledge bases and research focuses of cerebral ischemia-reperfusion from the perspective of mapping knowledge domain. Brain Res Bull. 2020;156:15–24. doi:10.1016/j.brainresbull.2019.12.004
   PubMed Web of Science ®Google Scholar
• Freeman LC. Centrality in social networks: conceptual clarification. SocNetw. 1979;1(3):215–239. doi:10.1016/0378-8733(78)90021-728
   Google Scholar
• Brandes U. A faster algorithm for betweenness centrality. J Math Sociol. 2001;25(2):163–177. doi:10.1080/0022250X.2001.9990249
   Web of Science ®Google Scholar
• Alder JK, Guo N, Kembou F, et al. Telomere length is a determinant of emphysema susceptibility. Am J Respir Crit Care Med. 2011;184(8):904–912. PMID: 21757622; PMCID: PMC3208661. doi:10.1164/rccm.201103-0520OC
   PubMed Web of Science ®Google Scholar
• Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest. 2006;129(3):746–752. PMID: 16537877. doi:10.1378/chest.129.3.746
   PubMed Web of Science ®Google Scholar
• Demedts M, Behr J, Buhl R, et al.; IFIGENIA Study Group. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med. 2005;353(21):2229–2242. PMID: 16306520. doi:10.1056/NEJMoa042976
   PubMed Web of Science ®Google Scholar
• Gauldie J, Kolb M, Ask K, Martin G, Bonniaud P, Warburton D. Smad3 signaling involved in pulmonary fibrosis and emphysema. Proc Am Thorac Soc. 2006;3(8):696–702. PMID: 17065376; PMCID: PMC2647655. doi:10.1513/pats.200605-125SF
   PubMedGoogle Scholar
• Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008;246(3):697–722. doi:10.1148/radiol.2462070712
   PubMed Web of Science ®Google Scholar
• Alder JK, Hanumanthu VS, Strong MA, et al. Diagnostic utility of telomere length testing in a hospital-based setting. Proc Natl Acad Sci USA. 2018;115(10):E2358–E2365. doi:10.1073/pnas.1720427115
   PubMed Web of Science ®Google Scholar
• Cottin V, Nunes H, Brillet PY, et al. Groupe d’Etude et de Recherche sur les Maladies Orphelines Pulmonaires (GERM O P). Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J. 2005;26(4):586–593. PMID: 16204587. doi:10.1183/09031936.05.00021005
   PubMed Web of Science ®Google Scholar
• Akagi T, Matsumoto T, Harada T, et al. Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis. Respir Med. 2009;103(8):1209–1215. doi:10.1016/j.rmed.2009.02.001
   PubMed Web of Science ®Google Scholar
• Cottin V, Cordier JF. The syndrome of combined pulmonary fibrosis and emphysema. Chest. 2009;136(1):1–2. doi:10.1378/chest.09-0538
   PubMed Web of Science ®Google Scholar
• Cottin V, Le Pavec J, Prévot G, et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur Respir J. 2010;35(1):105–111. doi:10.1183/09031936.00038709
   PubMed Web of Science ®Google Scholar
• Chen CM. Science mapping: a systematic review of the literature. J Data Inf Sci. 2017;2(2):1–40. doi:10.1515/jdis-2017-0006
   Google Scholar
• Lin H, Jiang S. Combined pulmonary fibrosis and emphysema (CPFE): an entity different from emphysema or pulmonary fibrosis alone. J Thorac Dis. 2015;7(4):767–779. PMID: 25973246; PMCID: PMC4419325. doi:10.3978/j.issn.2072-1439.2015.04.17
   PubMed Web of Science ®Google Scholar
• Ryerson CJ, Hartman T, Elicker BM, et al. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest. 2013;144(1):234–240. PMID: 23370641. doi:10.1378/chest.12-2403
   PubMed Web of Science ®Google Scholar
• Raghu G, Collard HR, Egan JJ, et al; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824. PMID: 21471066; PMCID: PMC5450933. doi:10.1164/rccm.2009-040GL
   PubMed Web of Science ®Google Scholar
• Travis WD, Costabel U, Hansell DM, et al; ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733–748. PMID: 24032382; PMCID: PMC5803655. doi:10.1164/rccm.201308-1483ST
   PubMed Web of Science ®Google Scholar
• Valenzuela C, Torrisi SE, Kahn N, Quaresma M, Stowasser S, Kreuter M. Ongoing challenges in pulmonary fibrosis and insights from the nintedanib clinical programme. Respir Res. 2020;21(1):7. PMID: 31906942; PMCID: PMC6945404. doi:10.1186/s12931-019-1269-6
   PubMed Web of Science ®Google Scholar
• Jacob J, Bartholmai BJ, Rajagopalan S, et al. Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis. Eur Respir J. 2017;50(1):1700379. PMID: 28679612. doi:10.1183/13993003.00379-2017
   PubMed Web of Science ®Google Scholar
• Lynch DA, Sverzellati N, Travis WD, et al. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. Lancet Respir Med. 2018;6(2):138–153. PMID: 29154106. doi:10.1016/S2213-2600(17)30433-2
   PubMed Web of Science ®Google Scholar
• Raghu G, Remy-Jardin M, Myers JL, et al; American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Latin American Thoracic Society. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198(5):e44–e68. PMID: 30168753. doi:10.1164/rccm.201807-1255ST
   PubMed Web of Science ®Google Scholar
• Birch J, Barnes PJ, Passos JF. Mitochondria, telomeres and cell senescence: implications for lung ageing and disease. Pharmacol Ther. 2018;183:34–49. PMID: 28987319. doi:10.1016/j.pharmthera.2017.10.005
   PubMed Web of Science ®Google Scholar
• Richeldi L, Collard HR, Jones MG. Idiopathic pulmonary fibrosis. Lancet. 2017;389(10082):1941–1952. PMID: 28365056. doi:10.1016/S0140-6736(17)30866-8
   PubMed Web of Science ®Google Scholar
• Schafer MJ, White TA, Iijima K, et al. Cellular senescence mediates fibrotic pulmonary disease. Nat Commun. 2017;8:14532. PMID: 28230051; PMCID: PMC5331226. doi:10.1038/ncomms14532
   PubMed Web of Science ®Google Scholar
• Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med. 2011;208(7):1339–1350. PMID: 21727191; PMCID: PMC3136685. doi:10.1084/jem.20110551
   PubMed Web of Science ®Google Scholar
• King TE, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet. 2011;378(9807):1949–1961. PMID: 21719092. doi:10.1016/S0140-6736(11)60052-4
   PubMed Web of Science ®Google Scholar
• Meiners S, Eickelberg O, Königshoff M. Hallmarks of the ageing lung. Eur Respir J. 2015;45(3):807–827. PMID: 25657021. doi:10.1183/09031936.00186914
   PubMed Web of Science ®Google Scholar
• Fingerlin TE, Murphy E, Zhang W, et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet. 2013;45(6):613–620. PMID: 23583980; PMCID: PMC3677861. doi:10.1038/ng.2609
   PubMed Web of Science ®Google Scholar
• Liu G, Philp AM, Corte T, et al. Therapeutic targets in lung tissue remodelling and fibrosis. Pharmacol Ther. 2021;225:107839. PMID: 33774068. doi:10.1016/j.pharmthera.2021.107839
   PubMed Web of Science ®Google Scholar
• Reyfman PA, Walter JM, Joshi N, et al. Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis. Am J Respir Crit Care Med. 2019;199(12):1517–1536. PMID: 30554520; PMCID: PMC6580683. doi:10.1164/rccm.201712-2410OC
   PubMed Web of Science ®Google Scholar
• Adams TS, Schupp JC, Poli S, et al. Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis. Sci Adv. 2020;6(28):eaba1983. PMID: 32832599; PMCID: PMC7439502. doi:10.1126/sciadv.aba1983
   PubMed Web of Science ®Google Scholar
• Hogan BL, Barkauskas CE, Chapman HA, et al. Repair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell function. Cell Stem Cell. 2014;15(2):123–138. PMID: 25105578; PMCID: PMC4212493. doi:10.1016/j.stem.2014.07.012
   PubMed Web of Science ®Google Scholar
• Huleihel L, Levine M, Rojas M. The potential of cell-based therapy in lung diseases. Expert Opin Biol Ther. 2013;13(10):1429–1440. PMID: 23984902. doi:10.1517/14712598.2013.833603
   PubMed Web of Science ®Google Scholar
• Chilosi M, Poletti V, Rossi A. The pathogenesis of COPD and IPF: distinct horns of the same devil? Respir Res. 2012;13(1):3. PMID: 22235752; PMCID: PMC3282644. doi:10.1186/1465-9921-13-3
   PubMedGoogle Scholar
• Ley B, Ryerson CJ, Vittinghoff E, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012;156(10):684–691. PMID: 22586007. doi:10.7326/0003-4819-156-10-201205150-00004
   PubMed Web of Science ®Google Scholar
• Kinnula VL, Vuorinen K, Ilumets H, Rytilä P, Myllärniemi M. Thiol proteins, redox modulation and parenchymal lung disease. Curr Med Chem. 2007;14(2):213–222. PMID: 17266580. doi:10.2174/092986707779313345
   PubMed Web of Science ®Google Scholar
• Selman M, King TE, Pardo A; American Thoracic Society; European Respiratory Society; American College of Chest Physicians. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 2001;134(2):136–151. PMID: 11177318. doi:10.7326/0003-4819-134-2-200101160-00015
   PubMed Web of Science ®Google Scholar
• Rangasamy T, Cho CY, Thimmulappa RK, et al. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest. 2004;114(9):1248–1259. PMID: 15520857; PMCID: PMC524225. doi:10.1172/JCI21146
   PubMed Web of Science ®Google Scholar
• Aoshiba K, Yokohori N, Nagai A. Alveolar wall apoptosis causes lung destruction and emphysematous changes. Am J Respir Cell Mol Biol. 2003;28(5):555–562. PMID: 12707011. doi:10.1165/rcmb.2002-0090OC
   PubMed Web of Science ®Google Scholar
• Baarsma HA, Königshoff M. ‘WNT-er is coming’: WNT signalling in chronic lung diseases. Thorax. 2017;72(8):746–759. PMID: 28416592; PMCID: PMC5537530. doi:10.1136/thoraxjnl-2016-209753
   PubMed Web of Science ®Google Scholar
• Barkauskas CE, Cronce MJ, Rackley CR, et al. Type 2 alveolar cells are stem cells in adult lung. J Clin Invest. 2013;123(7):3025–3036. PMID: 23921127; PMCID: PMC3696553. doi:10.1172/JCI68782
   PubMed Web of Science ®Google Scholar
• Rock JR, Barkauskas CE, Cronce MJ, et al. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci USA. 2011;108(52):E1475–83. PMID: 22123957; PMCID: PMC3248478. doi:10.1073/pnas.1117988108
   PubMed Web of Science ®Google Scholar
• Parker MW, Rossi D, Peterson M, et al. Fibrotic extracellular matrix activates a profibrotic positive feedback loop. J Clin Invest. 2014;124(4):1622–1635. PMID: 24590289; PMCID: PMC3971953. doi:10.1172/JCI71386
   PubMed Web of Science ®Google Scholar
• Bonniaud P, Kolb M, Galt T, et al. Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J Immunol. 2004;173(3):2099–2108. PMID: 15265946. doi:10.4049/jimmunol.173.3.2099
   PubMed Web of Science ®Google Scholar
• Lagente V, Le Quement C, Boichot E. Macrophage metalloelastase (MMP-12) as a target for inflammatory respiratory diseases. Expert Opin Ther Targets. 2009;13(3):287–295. PMID: 19236151. doi:10.1517/14728220902751632
   PubMed Web of Science ®Google Scholar
• Crosby LM, Waters CM. Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol. 2010;298(6):L715–31. PMID: 20363851; PMCID: PMC2886606. doi:10.1152/ajplung.00361.2009
   PubMed Web of Science ®Google Scholar
• Demedts IK, Morel-Montero A, Lebecque S, et al. Elevated MMP-12 protein levels in induced sputum from patients with COPD. Thorax. 2006;61(3):196–201. PMID: 16308335; PMCID: PMC2080750. doi:10.1136/thx.2005.042432
   PubMed Web of Science ®Google Scholar
• Tzouvelekis A, Ntolios P, Bouros D. Stem cell treatment for chronic lung diseases. Respiration. 2013;85(3):179–192. PMID: 23364286. doi:10.1159/000346525
   PubMed Web of Science ®Google Scholar
• Katsha AM, Ohkouchi S, Xin H, et al. Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Mol Ther. 2011;19(1):196–203. PMID: 20842104; PMCID: PMC3017437. doi:10.1038/mt.2010.192
   PubMed Web of Science ®Google Scholar
• Aguilar S, Scotton CJ, McNulty K, et al. Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fibrosis. PLoS One. 2009;4(11):e8013. PMID: 19956603; PMCID: PMC2779453. doi:10.1371/journal.pone.0008013
   PubMed Web of Science ®Google Scholar
• Lama VN, Flaherty KR, Toews GB, et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med. 2003;168(9):1084–1090. PMID: 12917227. doi:10.1164/rccm.200302-219OC
   PubMed Web of Science ®Google Scholar
• Lynch JP, Saggar R, Weigt SS, Ross DJ, Belperio JA. Overview of lung transplantation and criteria for selection of candidates. Semin Respir Crit Care Med. 2006;27(5):441–469. PMID: 17072794. doi:10.1055/s-2006-954604
   PubMed Web of Science ®Google Scholar
• American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001, Am J Respir Crit Care Med. 2002;165(2):277–304. PMID: 11790668. doi:10.1164/ajrccm.165.2.ats01
   PubMedGoogle Scholar
• King CS, Nathan SD. Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities. Lancet Respir Med. 2017;5(1):72–84. PMID: 27599614. doi:10.1016/S2213-2600(16)30222-3
   PubMed Web of Science ®Google Scholar
• Richeldi L, du Bois RM, Raghu G, et al. INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2071–2082. PMID: 24836310. doi:10.1056/NEJMoa1402584
   PubMed Web of Science ®Google Scholar
• Raghu G, Rochwerg B, Zhang Y, et al; American Thoracic Society; European Respiratory society; Japanese Respiratory Society; Latin American Thoracic Association. An official ATS/ERS/JRS/ALAT Clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192(2):e3–19. PMID: 26177183. doi:10.1164/rccm.201506-1063ST
   PubMed Web of Science ®Google Scholar
• King TE, Bradford WZ, Castro-Bernardini S, et al.; ASCEND Study Group. A Phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2083–2092. PMID: 24836312. doi:10.1056/NEJMoa1402582
   PubMed Web of Science ®Google Scholar
• Christie JD, Edwards LB, Aurora P, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report--2008. J Heart Lung Transplant. 2008;27(9):957–969. PMID: 18765187. doi:10.1016/j.healun.2008.07.018
   PubMed Web of Science ®Google Scholar
• Orens JB, Estenne M, Arcasoy S, et al. Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2006;25(7):745–755. PMID: 16818116. doi:10.1016/j.healun.2006.03.011
   PubMed Web of Science ®Google Scholar
• Egan TM, Murray S, Bustami RT, et al. Development of the new lung allocation system in the United States. Am J Transplant. 2006;6(5 Pt 2):1212–1227. PMID: 16613597. doi:10.1111/j.1600-6143.2006.01276.x
   PubMed Web of Science ®Google Scholar
• Iribarne A, Russo MJ, Davies RR, et al. Despite decreased wait-list times for lung transplantation, lung allocation scores continue to increase. Chest. 2009;135(4):923–928. PMID: 19017874. doi:10.1378/chest.08-2052
   PubMed Web of Science ®Google Scholar
• Christie JD, Shah CV, Kawut SM, et al.; Lung Transplant Outcomes Group. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am J Respir Crit Care Med. 2009;180(10):1010–1015. PMID: 19661249; PMCID: PMC2778153. doi:10.1164/rccm.200901-0118OC
   PubMed Web of Science ®Google Scholar
• Covarrubias M, Ware LB, Kawut SM, et al.; Lung Transplant Outcomes Group. Plasma intercellular adhesion molecule-1 and von Willebrand factor in primary graft dysfunction after lung transplantation. Am J Transplant. 2007;7(11):2573–2578. PMID: 17908278. doi:10.1111/j.1600-6143.2007.01981.x
   PubMed Web of Science ®Google Scholar
• Hoffman SA, Wang L, Shah CV, et al.; Lung Transplant Outcomes Group. Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Am J Transplant. 2009;9(2):389–396. PMID: 19120076; PMCID: PMC2821938. doi:10.1111/j.1600-6143.2008.02497.x
   PubMed Web of Science ®Google Scholar
• Diamond JM, Lederer DJ, Kawut SM, et al.; Lung Transplant Outcomes Group. Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis. Am J Transplant. 2011;11(11):2517–2522. PMID: 21883907; PMCID: PMC3206646. doi:10.1111/j.1600-6143.2011.03702.x
   PubMed Web of Science ®Google Scholar
• Attili AK, Kazerooni EA, Gross BH, Flaherty KR, Myers JL, Martinez FJ. Smoking-related interstitial lung disease: radiologic-clinical-pathologic correlation. Radiographics. 2008;28(5):1383–1396. PMID: 18794314. doi:10.1148/rg.285075223
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, et al. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532–555. PMID: 17507545. doi:10.1164/rccm.200703-456SO
   PubMed Web of Science ®Google Scholar
• Trappe A, Donnelly SC, McNally P, Coppinger JA. Role of extracellular vesicles in chronic lung disease. Thorax. 2021;76(10):1047–1056. PMID: 33712504; PMCID: PMC8461402. doi:10.1136/thoraxjnl-2020-216370
   PubMed Web of Science ®Google Scholar
• GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the global burden of disease study 2017, Lancet Respir Med. 2020;8(6):585–596. PMID: 32526187; PMCID: PMC7284317. doi:10.1016/S2213-2600(20)30105-3
   PubMed Web of Science ®Google Scholar
• Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389(10082):1931–1940. PMID: 28513453. doi:10.1016/S0140-6736(17)31222-9
   PubMed Web of Science ®Google Scholar
• Genschmer KR, Russell DW, Lal C, et al. Activated PMN exosomes: pathogenic entities causing matrix destruction and disease in the lung. Cell. 2019;176(1–2):113–126.e15. PMID: 30633902; PMCID: PMC6368091. doi:10.1016/j.cell.2018.12.002
   PubMed Web of Science ®Google Scholar
• Bezerra FS, Lanzetti M, Nesi RT, et al. Oxidative stress and inflammation in acute and chronic lung injuries. Antioxidants. 2023;12(3):548. PMID: 36978796; PMCID: PMC10045332. doi:10.3390/antiox12030548
   Web of Science ®Google Scholar
• JafariNezhad A, YektaKooshali MH. Lung cancer in idiopathic pulmonary fibrosis: a systematic review and meta-analysis. PLoS One. 2018;13(8):e0202360. PMID: 30114238; PMCID: PMC6095562. doi:10.1371/journal.pone.0202360
   PubMed Web of Science ®Google Scholar
• Ballester B, Milara J, Cortijo J. Idiopathic pulmonary fibrosis and lung cancer: mechanisms and molecular targets. Int J Mol Sci. 2019;20(3):593. PMID: 30704051; PMCID: PMC6387034. doi:10.3390/ijms20030593
   PubMed Web of Science ®Google Scholar
• de Koning HJ, van der Aalst CM, de Jong PA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382(6):503–513. PMID: 31995683. doi:10.1056/NEJMoa1911793
   PubMed Web of Science ®Google Scholar
• Verma S, Dutta A, Dahiya A, Kalra N. Quercetin-3-Rutinoside alleviates radiation-induced lung inflammation and fibrosis via regulation of NF-κB/TGF-β1 signaling. Phytomedicine. 2022;99:154004. doi:10.1016/j.phymed.2022.154004
   PubMed Web of Science ®Google Scholar
• Zhang B, Li P, Li J, Liu X, Wu W. Effect of Oxidative Stress on Diaphragm Dysfunction and Exercise Intervention in Chronic Obstructive Pulmonary Disease. Front Physiol. 2021;12:684453. doi:10.3389/fphys.2021.684453
   PubMed Web of Science ®Google Scholar
• Xu ZH. Clinical Study of Moxibustion-Medicine Combination in the Treatment of Chronic Obstructive Pulmonary Disease Combined with Interstitial Fibrosis [MA thesis]. Shandong University of Traditional Chinese Medicine; 2022.
   Google Scholar
• Li Y, Wang Y, Chen Y, et al. Research status and progress of Chinese medicine in the treatment of chronic obstructive pulmonary disease combined with pulmonary fibrosis. Clin Res Tradit Chin Med. 2018;10(26):146–148.
   Google Scholar